Can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy?

OBJECTIVE: To propose a new modality of retroperitoneal lymphadenectomy as a complementary treatment for patients with high risk, stage I nonseminomatous testicular tumor. MATERIALS AND METHODS: We studied 76 patients with stage I nonseminomatous testis tumor (T1-T4, NX, M0) treated by orchiectomy and retroperitoneal lymphadenectomy. Among them, 33 patients underwent unilateral retroperitoneal lymphadenectomy (URL) and 43 selective retroperitoneal lymphadenectomy (SRL). URL consisted in removing the lymph nodes located around the great vessel homolateral to the tumor (aorta or vena cava and iliac vessels), and anterior and posterior to the contralateral great vessel (aorta or vena cava). SRL was performed removing the lymph nodes located anterior and between the great vessels (aorta or vena cava) and laterally to the homolateral great vessel, extending the distal dissection until the level of inferior mesenteric artery. In these groups of patients, the incidence of disease recurrence, disease-free survival index, and frequency of post-operative aspermia were assessed. Mean post-operative follow-up time was 96 months. RESULTS: In the SRL group there was only 5% of aspermia versus 79% in the URL group (p < 0.0001). Tumor recurrence was observed in only 5 of the 76 patients and was not related to the surgical technique. The disease-free survival rate after the mean follow-up of 96 months was similar in both groups, being 94% in the SRL group and 93% in the URL group. CONCLUSION: The selective retroperitoneal lymphadenectomy constitutes an effective technique with a lower morbidity than unilateral lymphadenectomy, representing an excellent option for the management of patients with high-risk, stage I nonseminomatous testis tumor.

Saved in:
Bibliographic Details
Main Authors: Arruda,Homero O., Paula,Adriano A.P., Suarez,Ruben, Cury,José, Srougi,Miguel
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Urologia 2003
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382003000500004
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1677-55382003000500004
record_format ojs
spelling oai:scielo:S1677-553820030005000042004-03-17Can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy?Arruda,Homero O.Paula,Adriano A.P.Suarez,RubenCury,JoséSrougi,Miguel testis germ cell tumor neoplasm metastasis lymph node excision OBJECTIVE: To propose a new modality of retroperitoneal lymphadenectomy as a complementary treatment for patients with high risk, stage I nonseminomatous testicular tumor. MATERIALS AND METHODS: We studied 76 patients with stage I nonseminomatous testis tumor (T1-T4, NX, M0) treated by orchiectomy and retroperitoneal lymphadenectomy. Among them, 33 patients underwent unilateral retroperitoneal lymphadenectomy (URL) and 43 selective retroperitoneal lymphadenectomy (SRL). URL consisted in removing the lymph nodes located around the great vessel homolateral to the tumor (aorta or vena cava and iliac vessels), and anterior and posterior to the contralateral great vessel (aorta or vena cava). SRL was performed removing the lymph nodes located anterior and between the great vessels (aorta or vena cava) and laterally to the homolateral great vessel, extending the distal dissection until the level of inferior mesenteric artery. In these groups of patients, the incidence of disease recurrence, disease-free survival index, and frequency of post-operative aspermia were assessed. Mean post-operative follow-up time was 96 months. RESULTS: In the SRL group there was only 5% of aspermia versus 79% in the URL group (p < 0.0001). Tumor recurrence was observed in only 5 of the 76 patients and was not related to the surgical technique. The disease-free survival rate after the mean follow-up of 96 months was similar in both groups, being 94% in the SRL group and 93% in the URL group. CONCLUSION: The selective retroperitoneal lymphadenectomy constitutes an effective technique with a lower morbidity than unilateral lymphadenectomy, representing an excellent option for the management of patients with high-risk, stage I nonseminomatous testis tumor.info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.29 n.5 20032003-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382003000500004en10.1590/S1677-55382003000500004
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Arruda,Homero O.
Paula,Adriano A.P.
Suarez,Ruben
Cury,José
Srougi,Miguel
spellingShingle Arruda,Homero O.
Paula,Adriano A.P.
Suarez,Ruben
Cury,José
Srougi,Miguel
Can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy?
author_facet Arruda,Homero O.
Paula,Adriano A.P.
Suarez,Ruben
Cury,José
Srougi,Miguel
author_sort Arruda,Homero O.
title Can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy?
title_short Can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy?
title_full Can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy?
title_fullStr Can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy?
title_full_unstemmed Can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy?
title_sort can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy?
description OBJECTIVE: To propose a new modality of retroperitoneal lymphadenectomy as a complementary treatment for patients with high risk, stage I nonseminomatous testicular tumor. MATERIALS AND METHODS: We studied 76 patients with stage I nonseminomatous testis tumor (T1-T4, NX, M0) treated by orchiectomy and retroperitoneal lymphadenectomy. Among them, 33 patients underwent unilateral retroperitoneal lymphadenectomy (URL) and 43 selective retroperitoneal lymphadenectomy (SRL). URL consisted in removing the lymph nodes located around the great vessel homolateral to the tumor (aorta or vena cava and iliac vessels), and anterior and posterior to the contralateral great vessel (aorta or vena cava). SRL was performed removing the lymph nodes located anterior and between the great vessels (aorta or vena cava) and laterally to the homolateral great vessel, extending the distal dissection until the level of inferior mesenteric artery. In these groups of patients, the incidence of disease recurrence, disease-free survival index, and frequency of post-operative aspermia were assessed. Mean post-operative follow-up time was 96 months. RESULTS: In the SRL group there was only 5% of aspermia versus 79% in the URL group (p < 0.0001). Tumor recurrence was observed in only 5 of the 76 patients and was not related to the surgical technique. The disease-free survival rate after the mean follow-up of 96 months was similar in both groups, being 94% in the SRL group and 93% in the URL group. CONCLUSION: The selective retroperitoneal lymphadenectomy constitutes an effective technique with a lower morbidity than unilateral lymphadenectomy, representing an excellent option for the management of patients with high-risk, stage I nonseminomatous testis tumor.
publisher Sociedade Brasileira de Urologia
publishDate 2003
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382003000500004
work_keys_str_mv AT arrudahomeroo canselectiveretroperitoneallymphadenectomybebetterthanunilateralretroperitoneallymphadenectomy
AT paulaadrianoap canselectiveretroperitoneallymphadenectomybebetterthanunilateralretroperitoneallymphadenectomy
AT suarezruben canselectiveretroperitoneallymphadenectomybebetterthanunilateralretroperitoneallymphadenectomy
AT curyjose canselectiveretroperitoneallymphadenectomybebetterthanunilateralretroperitoneallymphadenectomy
AT srougimiguel canselectiveretroperitoneallymphadenectomybebetterthanunilateralretroperitoneallymphadenectomy
_version_ 1756427927516348416